Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | IL20 |
| Upstream (Parents) |
|---|
| (<<) AKT1 → IL20 |
| (<<) GDF15 → IL20 |
| (<<) KRT5 → IL20 |
| (<<) MESDC1 → IL20 |
| (<<) MLPH → IL20 |
| (<<) MMP7 → IL20 |
| (<<) N4BP3 → IL20 |
| (<<) PIM1 → IL20 |
| (<<) PLCD4 → IL20 |
| (<<) SERPINB5 → IL20 |
| (<<) SLC16A6 → IL20 |
| (<<) SPDEF → IL20 |
| (<<) SPR → IL20 |
| (<<) SULT1A2 → IL20 |
| (<<) UBE2E3 → IL20 |
| Downstream (Children) |
|---|
| IL20 → ADCY9 (>>) |
| IL20 → CPD (>>) |
| IL20 → EGF (>>) |
| IL20 → FAM83A (>>) |
| IL20 → FUT2 (>>) |
| IL20 → GAD1 (>>) |
| IL20 → NDRG1 (>>) |
| IL20 → NDST1 (>>) |
| IL20 → PI3 (>>) |
| IL20 → RDH16 (>>) |
| IL20 → RNASE7 (>>) |
| IL20 → RND3 (>>) |
| IL20 → SPINK5 (>>) |
| IL20 → SULT2B1 (>>) |
| IL20 → TRIB1 (>>) |
